It has been shown previously that a novel nitrooxy derivative of celecoxib exerts antiproliferative and pro-apoptotic effects in human colon cancer cells. The aim of this study was to elucidate whether these biological properties depend on COX-2 inhibition and/or NO release. Therefore, the derivative was decomposed into the parent compound celecoxib and the NO donor benzyl nitrate and the biological role of each was tested in COX-2-positive (HT-29) and -negative (SW-480) colon cancer cells. The main findings were that the nitro-oxy derivative behaved like celecoxib in HT-29 cells in terms of COX-2 and ERK/MAPK inhibition, as well as induction of apoptosis, while the benzyl nitrate had no such effects. Interestingly, the beta-catenin system was activated by the nitro-oxy derivative as well as by benzyl nitrate alone more potently than by the parent compound celecoxib, suggesting a possible regulatory role for NO. In SW480 cells, these activities were substantially less pronounced, suggesting the presence of COX-2-dependent mechanisms in the modulation of these parameters.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Characterization of a multianalyte GC-MS/MS procedure for detecting and quantifying polycyclic aromatic hydrocarbons (PAHs) and PAH derivatives from air particulate matter for an improved risk assessment.
Environ Pollut
December 2019
Helmholtz Centre for Environmental Research GmbH - UFZ, Dep. of Molecular Systems Biology, Permoserstr. 15, 04318 Leipzig, Germany; University of Leipzig, Faculty of Life Sciences, Institute of Biochemistry, Talstr. 33, 04103 Leipzig, Germany.
A correct description of the concentration and distribution of particle bound polycyclic aromatic hydrocarbons is important for risk assessment of atmospheric particulate matter. A new targeted GC-MS/MS method was developed for analyzing 64 PAHs including compounds with a molecular weight >300, as well as nitro-, methyl-, oxy- and hydroxyl derivatives in a single analysis. The instrumental LOD ranged between 0.
View Article and Find Full Text PDFMethod development for simultaneous analyses of polycyclic aromatic hydrocarbons and their nitro-, oxy-, hydroxy- derivatives in sediments.
Talanta
December 2019
The State Key Laboratory of Pollution Control and Resource Reuse, School of the Environment, Nanjing University, Nanjing, 210023, China. Electronic address:
It is important to establish an available analytical method for polycyclic aromatic hydrocarbons (PAHs), nitrated PAHs (nitro-PAHs), oxygenated forms of PAHs (oxy-PAHs), and hydroxy-PAHs (OH-PAHs) in sediment samples due to the fact that they co-exist in various environmental mediates, particularly in sediment. In this study, an analytical method has been developed and validated for the quantification of PAHs, nitro-PAHs, oxy-PAHs, and OH-PAHs in sediment samples. The sediment samples were extracted by accelerated solvent extraction and cleaned up with SPE alumina-n combining with aminopropyl cartridges.
View Article and Find Full Text PDFSupercritical fluid extraction with carbon nanotubes as a solid collection trap for the analysis of polycyclic aromatic hydrocarbons and their derivatives.
J Chromatogr A
May 2015
State Key Laboratory of Heavy Oil Processing, College of Chemical Engineering, China University of Petroleum, Beijing 102249, China. Electronic address:
A supercritical fluid extraction (SFE) method with an online solid collection trap has been developed for the quantitative analysis of 16 polycyclic aromatic hydrocarbons (PAHs) and 15 typical PAH derivatives in solid matrix. Compared with liquid trapping and C18 solid-phase trapping, multi-walled carbon nanotubes (CNTs) were proved to be the most efficient trapping sorbent for the collection of PAHs and their nitro-, oxy- and alkyl-derivatives. The proposed extraction-collection procedure was systematically optimized in terms of pressure, temperature, extraction time, trapping materials, supercritical fluid flow rate, co-solvent type, and co-solvent percentage, taking into account the interaction between these variables.
View Article and Find Full Text PDFA novel nitro-oxy substituted analogue of rofecoxib reduces human colon cancer cell growth.
Mol Cell Biochem
February 2012
Department of Experimental Medicine and Oncology, University of Torino, Turin, Italy.
Rofecoxib is a specific COX-2 inhibitor able to exert antiproliferative activity against colorectal cancer cells. It was withdrawn from the market after the demonstration of an increased risk of cardiovascular complications after prolonged use. Nevertheless, it remains an interesting compound for laboratory research as an experimental COX-2 inhibitor.
View Article and Find Full Text PDFAntiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines.
Mol Cell Biochem
April 2011
Department of Experimental Medicine and Oncology, University of Torino, Turin, Italy.
The inducible COX-2 enzyme is over-expressed in human breast cancer and its over-expression generally correlates with angiogenesis, deregulation of apoptosis and worse prognosis. This observation may explain the beneficial effect of nonsteroidal anti-inflammatory drugs and COX-2 inhibitors on breast cancer treatment. Here, we evaluated the antiproliferative activity of celecoxib, a selective COX-2 inhibitor, and its nitro-oxy derivative on human breast cancer cells characterized by low and high COX-2 expression, respectively.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!